(Q34548916)

3 August 2017

1 reference

title

Promotility medications--now and in the future (English)

1 reference

3 August 2017

1 reference

Karamanolis G

1

1 reference

PubMed ID

16849857

3 August 2017

Tack J

series ordinal

2

1 reference

3 August 2017

1 January 2006

1 reference

3 August 2017

1 reference

3 August 2017

24

1 reference

3 August 2017

3-4

1 reference

3 August 2017

297-307

1 reference

Recent advances in the pharmacology of gastrointestinal prokinetics

3 August 2017

1 reference

Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics

21 January 2018

1 reference

5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract

21 January 2018

1 reference

Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis

21 January 2018

1 reference

Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial

21 January 2018

1 reference

Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia

21 January 2018

1 reference

Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management

21 January 2018

1 reference

Review article: cardiac adverse effects of gastrointestinal prokinetics

21 January 2018

1 reference

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

21 January 2018

1 reference

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

21 January 2018

1 reference

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

21 January 2018

1 reference

Effect of renzapride on transit in constipation-predominant irritable bowel syndrome

21 January 2018

1 reference

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study

21 January 2018

1 reference

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man

21 January 2018

1 reference

Function of opioids in the enteric nervous system

21 January 2018

1 reference

Preclinical studies of opioids and opioid antagonists on gastrointestinal function

21 January 2018

1 reference

Alvimopan, a selective peripherally acting mu-opioid antagonist

21 January 2018

1 reference

Selective postoperative inhibition of gastrointestinal opioid receptors

21 January 2018

1 reference

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000092883

1 reference

3 August 2017

1 reference

PubMed ID

16849857